Herein, we present a case of coexisting neuroendocrine carcinoma and conventional adenocarcinoma (collision tumor) in the ampulla of Vater, which has seldom been reported in the literature. A 51-year-old man presented with a month history of jaundice. MRCP disclosed about 1.9×1.8 cm sized heterogeneously enhancing mass in ampulla of Vater, causing obstructions of distal common bile duct. He underwent pylorus-preserving pancreaticoduodenectomy under the diagnosis on ampulla of Vater cancer. Pathologically, sections on the ampulla of Vater showed conventional ductal adenocarcinoma extended and collided with poorly differentiated neuroendocrine carcinoma. In conclusion, we hereby presented a case of coexisting neuroendocrine carcinoma and conventional adenocarcinoma in the ampulla of Vater. 
INTRODUCTION
Collision cancers are malignancies in the same organ or anatomical site that comprises at least two different tumor components, with no mixed or transitional area between the two components. Collision cancers are very rare in the ampulla of Vater. And, it is known that the prognosis of collision cancer is very poor even after radical resection. Herein, we present a case of coexisting neuroendocrine carcinoma and conventional adenocarcinoma (collision tumor) in the ampulla of Vater, which has seldom been reported in literature.
CASE
A 51-year-old man was presented with a month history of jaundice, pruritis and choluria. He had no history on medical problems, but was paraplegic due to his car accident. Physical examination showed acutely ill appearances without fever, with generalized skin and mucosal jaundice also being observed, but otherwise, his overall symptoms were unremarkable.
In laboratory findings, we found elevated serum levels No remarkable enlarged lymph nodes were seen in the abdomen (Fig. 1) . With the clinical diagnosis on tumor of the ampulla of Vater, endoscopic retrograde cholangiopancreatography (ERCP) was performed, which revealed huge prominent papilla and dilated common bile In this area, the immunochemical stain with CD56, NSE and synaptophysin was negative, and this area extended and collided with poorly differentiated neuroendocrine carcinoma (Fig. 3) . Thus, we finally diagnosed the condition as 'collision tumor' of adenocarcinoma and neuroendocrine carcinoma in ampulla of Vater.
DISCUSSION
The majority of neuroendocrine tumor (NET) occurs in the GI tract (67.5%) and in the bronchopulmonary system (25.3%). Within the GI tract, most NETs occur in the small intestine (41.8%), rectum (27.4%), and stomach (8.7%). 1 Less than 1% of NETs occur in the ampulla of Vater. Preoperative diagnosis of collision tumors is difficult due to its lack of specific symptoms and radiologic features. In addition, serum levels of tumor markers such as CEA and CA 19-9 are not significantly different from the adenocarcinoma patients. Although it is difficult to diagnose collision tumors preoperatively, radical resection of tumor is still the reasonable treatment choice for resectable tumors. Nevertheless, some studies insisted that it is debatable whether surgical resection is a proper treatment, because of its dismal prognosis. 19 Chemotherapy using gemcitabine has been widely used for periampullary malignancies clinically, but there is no proven efficacy for collision tumors in periampullary region. 19 This is probably due to the highly malignant nature of collision tumors and some unknown oncological features of collision tumor.
The prognosis of the patient in our report was poor.
Generally, neuroendocrine tumor has higher invasiveness and poorer prognosis than adenocarcinoma in collision tumor for ampulla of Vater. 20 
